Clinical Assessment of a Motorized Spinal Distraction Rod in the Severe to Early Scoliosis Child
NCT: NCT03330158 · COMPLETED
Brief Summary
The purpose of this biomedical research is to evaluate the feasibility of the treatment with the new spinal distraction device ASTS in patients aged 4 to 10 years with severe early onset scoliosis. The hypothesis of this project is that the new fully implantable motorized spinal distraction device may provide a correction of scoliosis and progressive elongation ensuring patient comfort and minimizing complications. The ASTS (for Active Scoliosis Treatment System) growing rod is a new fully implantable motorized spinal distraction device which can ensure a correction of scoliosis and progressive elongation ensuring patient comfort and minimizing complications.
Frequently Asked Questions
What is Clinical Assessment of a Motorized Spinal Distraction Rod in the Severe to Early Scoliosis Child?
Clinical Assessment of a Motorized Spinal Distraction Rod in the Severe to Early Scoliosis Child is a clinical trial registered under NCT03330158. Current status: COMPLETED.
What is the status of NCT03330158?
The current status of NCT03330158 (Clinical Assessment of a Motorized Spinal Distraction Rod in the Severe to Early Scoliosis Child) is: COMPLETED.
When did Clinical Assessment of a Motorized Spinal Distraction Rod in the Severe to Early Scoliosis Child start?
Clinical Assessment of a Motorized Spinal Distraction Rod in the Severe to Early Scoliosis Child started on 2019-02-05.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.